42Stockpicking

TVTX

Travere Therapeutics IncKøb· 75.0%· 5. jun. 2026
NASDAQ·Healthcare·USD
56.65USD
+3.27 (+6.12%)

Værdiansættelse (TTM)

P/Ei
EV/EBITDAi
P/Bi
33,7
96th %ile · 404p
P/Si
EV/Salesi
Div yieldi

Kursudvikling

Kun 283 handelsdage i databasen.

Pris

Data-readiness

10 års prishistorik er idealet for høj confidence.

Beregnet 10.6.2026basic
Prishistorik
1 år
Pris-dage
260
Årsregnskaber
15
Peers
0/0
Valuation
1/6
Fundamentals
7/8
Datovindue
2025-04-28 til 2026-05-08

Blokkere

  • Raw confidence is below the 0.95 high-confidence guardrail.

Mangler før højere confidence

  • Mangler ca. 9,0 års prishistorik før ideal/full.
  • Backfill mod 5 års priser for strong-readiness.
  • Kør compute-multiples for manglende valuation metrics.
  • Kør fetch-fundamentals-bulk/API fallback for manglende regnskabsmetrics.

Seneste assessment

TVTX vurderet 2026-06-10

Score
40.2%
Ikke high-confidence

Raw confidence is below the 0.95 high-confidence guardrail.

Sell watch placeholder

Stores exit-aware fields without issuing sell scores yet.

63%

Current drawdown: Future exit logic can use drawdown from recent high.

Trend break: Future exit logic can use moving-average trend breaks.

Valuation

Compares price paid with earnings, cash-generation proxies and sales.

29%

P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.

Earnings yield: Earnings yield is the inverse P/E lens.

Technicals

Checks trend, momentum and current damage from recent highs.

95%

6M momentum: Positive medium-term momentum confirms sponsorship.

Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.

Data quality

Checks whether the assessment has enough recent price, fundamental and valuation data.

58%

Price history depth: More than one trading year gives the technical pillar enough context.

Latest price freshness: Latest live or EOD price should be recent.

Macro/regime

Treats macro as context, not a standalone trading instruction.

46%

VIX: Normal volatility is supportive; panic or complacency is less clean.

10Y-2Y curve: Positive yield curve lowers recession stress.

Fundamentals

Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.

29%

Revenue growth 3Y: Sustained top-line growth supports durable compounding.

Gross margin: High gross margin gives room for reinvestment and downturns.

Peer/relative context

Adds relative context when sector peers have comparable data.

40%

Peer count: Peer context is only scored when comparable data exists.

P/E vs peers: P/E relative valuation needs both own multiple and peer median.

Insider activity

Net 90d (aktier)
-17.750
Net 90d (værdi)
-867.090 USD
Købere 90d
0
Cluster
DatoPersonRolleTypeAntalVærdiKilde
22.6.2026Inrig JulaCHIEF MEDICAL OFFICER◇ GAVE-468sec
12.6.2026Coughlin Timothy◆ OPT.10.000265.200 USDsec
12.6.2026Coughlin Timothy▼ SALG-10.000-500.747 USDsec
12.6.2026Baynes Roy D.◆ OPT.4.50096.210 USDsec
12.6.2026Baynes Roy D.▼ SALG-4.500-225.000 USDsec
19.5.2026Orwin John A· ANDET4.000sec
19.5.2026Meckler Jeffrey A· ANDET4.000sec
19.5.2026Poole Sandra· ANDET4.000sec
19.5.2026Baynes Roy D.· ANDET4.000sec
19.5.2026Bruhn Suzanne Louise· ANDET4.000sec
19.5.2026LYONS GARY A· ANDET4.000sec
19.5.2026Williams Brinkley Ruth· ANDET4.000sec
19.5.2026Coughlin Timothy· ANDET4.000sec
19.5.2026Squarer Ron· ANDET4.000sec
15.5.2026Coughlin Timothy▼ SALG-3.250-141.343 USDsec

Earnings

QuarterDateEPS actualEPS estEPS surpriseRevenue surprise
2026Q14.5.20260,05-0,06+187.0%+187.0%Beat
2025Q430.1.20260,370,37-0.8%-0.8%Inline
2025Q330.10.20250,59-0,09+794.1%+794.1%Beat
2025Q230.7.20250,130,04+225.0%+225.0%Beat